KENTA BIOTECH Trademark

Trademark Overview

On Tuesday, September 5, 2006, a trademark application was filed for KENTA BIOTECH with the United States Patent and Trademark Office. The USPTO has given the KENTA BIOTECH trademark a serial number of 79029600. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, September 5, 2016. This trademark is owned by Kenta Biotech AG. The KENTA BIOTECH trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations containing human monoclonal antibodies
kenta biotech

General Information

Serial Number79029600
Word MarkKENTA BIOTECH
Filing DateTuesday, September 5, 2006
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, September 5, 2016
Registration Number3275538
Registration DateTuesday, August 7, 2007
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 22, 2007

Trademark Statements

Disclaimer with Predetermined Text"BIOTECH"
Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations containing human monoclonal antibodies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 14, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKenta Biotech AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameKenta Biotech AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameKenta Biotech AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Friday, May 19, 2017NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, May 19, 2017DEATH OF INTERNATIONAL REGISTRATION
Saturday, June 20, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Friday, April 24, 2015GENERIC MADRID TRANSACTION SENT TO IB
Friday, April 24, 2015GENERIC MADRID TRANSACTION CREATED
Friday, November 14, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, March 14, 2014CANCELLED SECTION 71
Saturday, September 20, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, December 5, 2007FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, December 5, 2007FINAL DISPOSITION PROCESSED
Monday, November 19, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 7, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, May 22, 2007PUBLISHED FOR OPPOSITION
Wednesday, May 2, 2007NOTICE OF PUBLICATION
Friday, March 23, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 22, 2007ASSIGNED TO LIE
Monday, February 26, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 24, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 23, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 23, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 22, 2007REFUSAL PROCESSED BY IB
Wednesday, February 7, 2007NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, February 7, 2007REFUSAL PROCESSED BY MPU
Wednesday, February 7, 2007NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, February 6, 2007NON-FINAL ACTION WRITTEN
Monday, January 29, 2007ASSIGNED TO EXAMINER
Tuesday, November 14, 2006NEW APPLICATION ENTERED IN TRAM
Thursday, November 9, 2006SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

biotech kenta pharmaceutical preparations monoclonal antibodies containing namely human